Definition/General

Introduction:
-Renal angiomyolipoma is a benign mesenchymal tumor
-Belongs to PEComa family
-Composed of blood vessels, smooth muscle, and adipose tissue
-Excellent prognosis
-Associated with tuberous sclerosis complex.
Origin:
-Arises from perivascular epithelioid cells (PEC)
-Shows melanoma markers positivity
-mTOR pathway involvement
-Associated with TSC1/TSC2 mutations.
Classification:
-WHO 2022: Angiomyolipoma
-Classic triphasic
-Epithelioid angiomyolipoma
-Fat-poor angiomyolipoma
-Part of PEComa tumor family.
Epidemiology:
-Peak incidence 4th-5th decades
-Female predominance (4:1)
-Sporadic (80%) vs TSC-associated (20%)
-Bilateral/multiple in TSC
-Most common benign kidney tumor.

Clinical Features

Presentation:
-Asymptomatic (50%)
-Flank pain
-Retroperitoneal hemorrhage (large tumors >4 cm)
-Hematuria
-Palpable mass
-Wunderlich syndrome.
Symptoms:
-Abdominal/flank pain
-Sudden severe pain (hemorrhage)
-Hematuria
-Hypovolemic shock
-Nausea/vomiting
-Constitutional symptoms (bleeding).
Risk Factors:
-Tuberous sclerosis complex
-Female gender
-Estrogen exposure
-Pregnancy (growth acceleration)
-LAM syndrome
-TSC1/TSC2 mutations.
Screening:
-CT/MRI imaging
-Fat-containing lesion
-Heterogeneous enhancement
-Aneurysm formation
-TSC screening
-Family history.

Master Renal AML Pathology with RxDx

Access 100+ pathology videos and expert guidance with the RxDx app

Gross Description

Appearance:
-Well-circumscribed
-Yellow-gray color
-Soft consistency
-Heterogeneous cut surface
-Prominent fat
-Vascular spaces.
Characteristics:
-Lobulated surface
-Variegated appearance
-Yellow fatty areas
-Gray smooth muscle
-Vascular channels
-Hemorrhage (ruptured).
Size Location:
-Variable size (0.5-30 cm)
-Cortical location
-Exophytic growth
-Multiple/bilateral (TSC)
-Unilateral/solitary (sporadic).
Multifocality:
-Solitary (sporadic)
-Multiple/bilateral (TSC)
-Synchronous lesions
-Variable sizes
-Progressive growth.

Microscopic Description

Histological Features:
-Three components: blood vessels, smooth muscle, adipose tissue
-Thick-walled vessels
-Spindle cells (smooth muscle)
-Mature fat
-Variable proportions.
Cellular Characteristics:
-Spindle-shaped smooth muscle cells
-Epithelioid cells
-Mature adipocytes
-Endothelial cells
-Melanoma-like cells (epithelioid type).
Architectural Patterns:
-Fascicular smooth muscle
-Thick-walled vessels
-Mature adipose tissue
-Perivascular distribution
-Epithelioid nests (epithelioid type).
Grading Criteria:
-Benign tumor
-Epithelioid AML: Uncertain malignant potential
-Assessment: Cellular atypia
-Mitotic activity
-Necrosis.

Immunohistochemistry

Positive Markers:
-Melanoma markers: HMB-45+, Melan-A+
-Smooth muscle actin - positive
-Smooth muscle myosin - positive
-Cathepsin K - positive
-TFE3 - positive.
Negative Markers:
-Desmin - negative
-S-100 - negative
-Cytokeratins - negative
-CD68 - negative
-RCC marker - negative.
Diagnostic Utility:
-HMB-45 positivity diagnostic
-Melanoma markers distinguish from other mesenchymal tumors
-SMA confirms smooth muscle
-Desmin negative typical.
Molecular Subtypes:
-Classic AML: HMB-45+, SMA+
-Epithelioid AML: Strong melanoma markers
-Fat-poor AML: Same markers, less fat
-All types: mTOR pathway involvement.

Molecular/Genetic

Genetic Mutations:
-TSC1/TSC2 mutations
-mTOR pathway activation
-Loss of heterozygosity (chromosome 16p)
-TFE3 translocations (rare)
-Simple karyotype.
Molecular Markers:
-mTOR/S6K1 activation
-Tuberin/hamartin loss
-Autophagy dysregulation
-Cell growth pathways
-Melanocyte markers.
Prognostic Significance:
-Benign behavior (classic)
-Hemorrhage risk (>4 cm)
-Epithelioid type: Uncertain malignant potential
-Size predicts complications
-Excellent prognosis overall.
Therapeutic Targets:
-mTOR inhibitors (everolimus, sirolimus)
-Observation (<4 cm)
-Embolization
-Partial nephrectomy
-Ablative techniques.

Differential Diagnosis

Similar Entities:
-Renal cell carcinoma with fat
-Liposarcoma
-Leiomyosarcoma
-Epithelioid PEComa
-Melanoma metastasis
-Clear cell RCC.
Distinguishing Features:
-AML: HMB-45+, RCC markers-
-RCC: PAX8+, CA9+
-Liposarcoma: MDM2+, CDK4+
-Leiomyosarcoma: Desmin+, high grade
-Melanoma: S-100+, clinical correlation.
Diagnostic Challenges:
-Fat-poor AML
-Epithelioid AML
-RCC with hemorrhage
-Small biopsies
-Crush artifact.
Rare Variants:
-Epithelioid angiomyolipoma
-Angiomyolipoma with epithelial cysts
-Lymphangioleiomyomatosis-associated AML.

Sample Pathology Report

Template Format

Sample Pathology Report

Complete Report: This is an example of how the final pathology report should be structured for this condition.

Specimen Information

[Partial nephrectomy/enucleation] with well-circumscribed mass

Tumor Description

Angiomyolipoma measuring [X] cm with heterogeneous yellow-gray appearance

Three Components

Contains blood vessels ([prominent/moderate]), smooth muscle ([prominent/moderate]), and adipose tissue ([prominent/moderate/minimal])

Microscopic Features

Thick-walled blood vessels, spindle smooth muscle cells, and mature adipocytes in variable proportions

Epithelioid Features

Epithelioid features: [absent/present - uncertain malignant potential]

Immunohistochemistry

HMB-45: Positive, Melan-A: Positive, SMA: Positive, Desmin: Negative

TSC Association

[Multiple lesions suggest TSC - genetic counseling recommended / Solitary sporadic lesion]

Hemorrhage Risk

Size [>4 cm - increased hemorrhage risk / <4 cm - low risk]

Final Diagnosis

Angiomyolipoma, [X] cm, [classic/epithelioid/fat-poor] type

Management

[Observation recommended for lesions <4 cm / Consider intervention for large lesions >4 cm / mTOR inhibitors may be beneficial]